CYTOMEGALOVIRUS
Clinical trials for CYTOMEGALOVIRUS explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA vaccine aims to shield teens and young adults from common virus
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental mRNA vaccine (mRNA-1647) for cytomegalovirus (CMV) in healthy teens (9–15 years) and young women (16–25 years). The goal was to see if the vaccine is safe and triggers a strong immune response. Participants received either the vaccine or a placeb…
Matched conditions: CYTOMEGALOVIRUS
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:02 UTC
-
Moderna's mRNA vaccine cocktail passes early safety check
⭐️ VACCINE ⭐️ CompletedThis study tested the safety and immune response of several Moderna mRNA vaccines for COVID-19, seasonal flu, RSV, and CMV in 308 healthy adults aged 18 to 75. Researchers monitored side effects and measured antibody levels after vaccination. The goal was to ensure the vaccines a…
Matched conditions: CYTOMEGALOVIRUS
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
Saliva swab could spot hidden virus in kids
Knowledge-focused CompletedThis study looked at whether a simple saliva test can find cytomegalovirus (CMV) in children aged 3 months to 6 years. Researchers collected saliva samples from 655 children in daycares and a hospital emergency department. The goal was to see how common the virus is and to check …
Matched conditions: CYTOMEGALOVIRUS
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC